UPDATE: Genomed's Response to SEC Suspending Trading of GenoMed Shares

Press Releases | In the Media | Publications | Questions & Answers | Blog

The medical industry is currently a two trillion dollar a year market and is expanding at a rapid pace. The recent completion of the Human Genome Project has changed the way we view the treatment of disease and signifies a revolution in the medical industry. Medical Genomics is already catalyzing the change from treating disease to treating risk of disease. GenoMed is the leading company in the nascent field of preventive molecular medicine.

GenoMed discovers "master" disease gene; foundation for Next Generation DM^TM

Join Genomed's COIP (Clinical Outcomes Improvement Program). Click Here!

Flu Trial

West Nile Virus - Clinical Trial Information

Healthchip^® to Predict Cancers